Scientists test new cancer pill design
NCT ID NCT00777582
Summary
This early-stage study is testing two different pill versions of the same cancer drug, AZD2281, to see if the body absorbs them differently. It involves patients with advanced solid tumors that have not responded to standard treatments. The main goal is to compare the safety and absorption of a new tablet form against an older capsule form.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Randwick, 2031, Australia
-
Research Site
Leuven, 3000, Belgium
-
Research Site
Bellinzona, CH-6500, Switzerland
-
Research Site
Edinburgh, EH4 2XR, United Kingdom
-
Research Site
London, NW1 2PG, United Kingdom
-
Research Site
Manchester, M20 4BX, United Kingdom
-
Research Site
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Research Site
Northwood, HA6 2RN, United Kingdom
-
Research Site
Oxford, OX3 7LE, United Kingdom
-
Research Site
Sutton, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.